MedFirst Healthcare Services, Inc. (TPEX:4175)
Taiwan · Delayed Price · Currency is TWD 54.10
+0.40 (0.74%)
Jun 5, 2026, 1:13 PM CST
TPEX:4175 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,000 | 8,013 | 7,734 | 7,446 | 7,224 | 6,540 | |
Revenue Growth (YoY) | 2.61% | 3.60% | 3.87% | 3.08% | 10.46% | 10.34% |
Cost of Revenue | 5,407 | 5,412 | 5,351 | 5,177 | 5,018 | 4,614 |
Gross Profit | 2,593 | 2,601 | 2,383 | 2,269 | 2,206 | 1,927 |
Selling, General & Admin | 2,413 | 2,390 | 2,260 | 2,164 | 1,979 | 1,815 |
Operating Expenses | 2,412 | 2,390 | 2,260 | 2,164 | 1,978 | 1,814 |
Operating Income | 180.5 | 210.88 | 123.06 | 105.51 | 227.71 | 113.22 |
Interest Expense | -62.02 | -61.3 | -58.94 | -58.43 | -46.8 | -37.4 |
Interest & Investment Income | 5.8 | 6.52 | 5.83 | 8.47 | 3.12 | 1.79 |
Currency Exchange Gain (Loss) | -0.96 | -0.96 | 3.12 | -0.81 | 11.04 | -1.52 |
Other Non Operating Income (Expenses) | 31.16 | 30.96 | 22.6 | 20.83 | 24.1 | 13.95 |
EBT Excluding Unusual Items | 154.48 | 186.09 | 95.67 | 75.56 | 219.17 | 90.04 |
Impairment of Goodwill | - | - | - | -5.29 | -2.3 | -3.61 |
Gain (Loss) on Sale of Investments | - | - | -0.01 | -0.29 | 0.29 | - |
Gain (Loss) on Sale of Assets | 0.33 | 0.33 | -0.51 | -0.27 | 0.87 | -22.85 |
Asset Writedown | -0.75 | -0.75 | -0.34 | -0.17 | - | -1.37 |
Legal Settlements | - | - | - | - | 0.85 | -7.57 |
Other Unusual Items | 1.13 | 1.13 | 0.57 | 0.34 | 3.08 | 0.88 |
Pretax Income | 155.19 | 186.8 | 95.39 | 69.89 | 221.96 | 58.96 |
Income Tax Expense | 24.98 | 31.23 | 25.4 | 22.36 | 46.28 | -7.33 |
Earnings From Continuing Operations | 130.21 | 155.57 | 69.99 | 47.53 | 175.68 | 66.29 |
Minority Interest in Earnings | -0.06 | -0.03 | -0.17 | -0.73 | -4.82 | 1.64 |
Net Income | 130.15 | 155.54 | 69.82 | 46.8 | 170.86 | 67.93 |
Net Income to Common | 130.15 | 155.54 | 69.82 | 46.8 | 170.86 | 67.93 |
Net Income Growth | 12.26% | 122.79% | 49.17% | -72.61% | 151.53% | -38.16% |
Shares Outstanding (Basic) | 42 | 42 | 42 | 42 | 39 | 38 |
Shares Outstanding (Diluted) | 42 | 43 | 42 | 42 | 42 | 42 |
Shares Change (YoY) | -0.24% | 0.72% | 0.07% | -0.18% | 0.32% | 3.20% |
EPS (Basic) | 3.08 | 3.68 | 1.65 | 1.13 | 4.41 | 1.80 |
EPS (Diluted) | 3.07 | 3.64 | 1.65 | 1.12 | 4.09 | 1.69 |
EPS Growth | 12.21% | 120.82% | 46.83% | -72.58% | 142.01% | -38.67% |
Free Cash Flow | 616.12 | 624.53 | 407.3 | 573.42 | 780 | 592.88 |
Free Cash Flow Per Share | 14.56 | 14.63 | 9.61 | 13.54 | 18.39 | 14.02 |
Dividend Per Share | 3.000 | 3.000 | 1.600 | 1.600 | 2.600 | 1.459 |
Dividend Growth | 87.50% | 87.50% | - | -38.45% | 78.13% | -12.94% |
Gross Margin | 32.41% | 32.46% | 30.81% | 30.47% | 30.53% | 29.46% |
Operating Margin | 2.26% | 2.63% | 1.59% | 1.42% | 3.15% | 1.73% |
Profit Margin | 1.63% | 1.94% | 0.90% | 0.63% | 2.37% | 1.04% |
Free Cash Flow Margin | 7.70% | 7.79% | 5.27% | 7.70% | 10.80% | 9.06% |
EBITDA | 368.11 | 397.37 | 304.9 | 287.19 | 396.14 | 266.93 |
EBITDA Margin | 4.60% | 4.96% | 3.94% | 3.86% | 5.48% | 4.08% |
D&A For EBITDA | 187.61 | 186.49 | 181.84 | 181.68 | 168.42 | 153.72 |
EBIT | 180.5 | 210.88 | 123.06 | 105.51 | 227.71 | 113.22 |
EBIT Margin | 2.26% | 2.63% | 1.59% | 1.42% | 3.15% | 1.73% |
Effective Tax Rate | 16.10% | 16.72% | 26.63% | 31.99% | 20.85% | - |